ACS Selects Stanford's Carl Djerassi As Recipient Of 1991 Priestley Medal

The American Chemical Society has awarded Stanford University chemistry professor Carl Djerassi the 1991 Priestley Medal. The medal, which is ACS's highest honor and is widely regarded as the United States' most prestigious award in chemistry, will be presented to Djerassi next April at the society's national meeting in San Francisco. World-famous for developing the first oral contraceptive--"the pill"--Djerassi, 67, has had great success in academia and industry, in developed and developing

Written byBarbara Spector
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The American Chemical Society has awarded Stanford University chemistry professor Carl Djerassi the 1991 Priestley Medal. The medal, which is ACS's highest honor and is widely regarded as the United States' most prestigious award in chemistry, will be presented to Djerassi next April at the society's national meeting in San Francisco.

World-famous for developing the first oral contraceptive--"the pill"--Djerassi, 67, has had great success in academia and industry, in developed and developing countries, and in science and literature. He has been a pioneer in the development of antihistamines and topical corticosteroids and in the isolation, structural elucidation, and partial synthesis of steroids, lipids, and antibiotics, among other natural products. In addition, he played a leading role in the introduction into organic chemistry of several physical methods, including mass spectrometry and chiroptical techniques.

"I find it very stimulating to do different things at the same time," says Djerassi, who calls himself ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies